The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review

BACKGROUND: Checkpoint inhibitor immunotherapy has not proven clinically effective in glioblastoma. This lack of effectiveness may be partially attributable to the frequent administration of dexamethasone in glioblastoma patients. In this systematic review, we assess whether dexamethasone (1) affect...

ver descrição completa

Detalhes bibliográficos
Autores principales: Swildens, Kyra X, Sillevis Smitt, Peter A E, van den Bent, Martin J, French, Pim J, Geurts, Marjolein
Formato: Online Artigo Texto
Idioma:English
Publicado em: Oxford University Press 2022
Assuntos:
Meta-Analysis
Acesso em linha:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389427/
https://www.ncbi.nlm.nih.gov/pubmed/35990704
http://dx.doi.org/10.1093/noajnl/vdac087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389427/
https://www.ncbi.nlm.nih.gov/pubmed/35990704
http://dx.doi.org/10.1093/noajnl/vdac087

Registos relacionados